Figure 4. Assessment of efficacy, patient satisfaction, and
adverse effects
A) Efficacy of treatment was determined at week 6, 12, 33, and
52 after treatment was initiated by IGA grading. B) Patient
satisfaction was assessed at the final evaluation at week 52 by grading
satisfaction on a 5-point Likert scale (very dissatisfied, dissatisfied,
no opinion, satisfied and very satisfied). C) Treatment
associated adverse effects were reported by the patients after each FLE
treatment session through use of a questionnaire grading side-effects
according to experienced as mild, tolerable, unpleasant, or intolerable.